Browse > Article
http://dx.doi.org/10.5352/JLS.2022.32.1.11

Resveratrol Ameliorates NMDA-induced Mitochondrial Injury by Enhanced Expression of Heme Oxygenase-1 in HT-22 Neuronal Cells  

Kang, Jae Hoon (Department of Physiology, College of Medicine, Pusan National University)
Woo, Jae Suk (Department of Physiology, College of Medicine, Pusan National University)
Publication Information
Journal of Life Science / v.32, no.1, 2022 , pp. 11-22 More about this Journal
Abstract
N-methyl-D-aspartate (NMDA) receptors have received considerable attention regarding their involvement in glutamate-induced neuronal excitotoxicity. Resveratrol has been shown to exhibit neuroprotective effects against this kind of overactivation, but the underlying cellular mechanisms are not yet clearly understood. In this study, HT-22 neuronal cells were treated with NMDA in Mg2+-free buffer and subsequently used as an experimental model of glutamate excitotoxicity to elucidate the mechanisms of resveratrol-induced neuroprotection. We found that NMDA treatment causes a drop in MTT reduction ability, disrupts inside-negative transmembrane potential of mitochondria, depletes cellular ATP levels, and stimulates intracellular ROS production. Double fluorescence imaging studies demonstrated an increased formation of mitochondrial permeability transition (MPT) pores accompanied by apoptotic cell death, while cobalt protoporphyrin and bilirubin showed protective effects against NMDA-induced mitochondrial injury. On the other hand, zinc protoporphyrin IX significantly attenuated the protective effects of resveratrol which was itself shown to enhance heme oxygenase-1 (HO-1) mRNA and protein expression levels. In cells transfected with HO-1 small interfering RNA, resveratrol failed to suppress the NMDA-induced effects on MTT reduction ability and MPT pore formation. The present study suggests that resveratrol may prevent mitochondrial injury in NMDA- treated HT-22 cells and that enhanced expression of HO-1 is involved in the underlying cellular mechanism.
Keywords
Heme oxygenase-1; mitochondrial injury; NMDA excitotoxicity; neuroprotection; resveratrol;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A. and Brenner, D. A., et al. 1998. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1366, 177-196.   DOI
2 Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K. and Pintus, G. 2020. Potential adverse effects of resveratrol: a literature review. Int. J. Mol. Sci. 21, 2084.   DOI
3 Shetty, A. K. 2011. Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol. Ther. 131, 269-286.   DOI
4 Walker, M. C. 2018. Pathophysiology of status epilepticus. Neurosci. Lett. 667, 84-91.   DOI
5 Wu, Q. J. and Tymianski, M. 2018. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol. Brain 11, 15.   DOI
6 Marks, G. S. 1994. Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins. Cell Mol. Biol. 40, 863-870.
7 Song, X., Jensen, M. O., Jogini, V., Stein, R. A., Lee, C. H., Mchaourab, H. S., Shaw, D. E. and Gouaux, E. 2018. Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature 556, 515-519.   DOI
8 Yang, Q., Wang, B., Zang, W., Wang, X., Liu, Z., Li, W. and Jia, J. 2013. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 8, e70627.   DOI
9 Bastianetto, S. and Quirion, R. 2010. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp. Neurol. 225, 237-239.   DOI
10 Quincozes-Santos, A. and Gottfried, C. 2011. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann. N. Y. Acad. Sci. 1215, 72-78.   DOI
11 Chaturvedi, R. K. and Flint, B. M. 2013. Mitochondrial diseases of the brain. Free Radic. Biol. Med. 63, 1-29.   DOI
12 Chen, J. 2014. Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev. Neurosci. 25, 269-280.   DOI
13 Fukui, M., Choi, H. J. and Zhu, B. T. 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 800-813.   DOI
14 Johnson, K. A, Conn, P. J. and Niswender, C. M. 2009. Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol. Disord. Drug Targets 8, 475-491.   DOI
15 Kim, T. H., Park, J. H. and Woo, J. S. 2919. Resveratrol induces cell death through ROS dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. Mol. Med. Rep. 19, 3353-3360.
16 Kumar, A., Naidu, P. S., Seghal, N. and Padi, S. S. 2007. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79, 17-26.   DOI
17 Lee, J. G., Yon, J. M., Lin, C., Jung, A. Y., Jung, K. Y. and Nam, S. Y. 2012. Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons. Food Chem. Toxicol. 50, 3877-3885.   DOI
18 Lin, X., Wu, G., Huo, W. Q., Zhang, Y. and Jin, F. S. 2012. Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells. Int. J. Urol. 19, 757-764.   DOI
19 Lu, X., Ma, L., Ruan, L., Kong, Y., Mou, H., Zhang, Z., Wang, Z., Wang, J. M. and Le, Y. 2010. Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J. Neuroinflammation 7, 46.   DOI
20 Low, I. C., Chen, Z. X. and Pervaiz, S. 2010. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid. Redox Signal 13, 807-819.   DOI
21 Lyman, G. E. and DeVincenzo, J. P. 1967. Determination of picogram amounts of ATP using the luciferin-luciferase enzyme system. Anal. Biochem. 21, 435-443.   DOI
22 Marks, G. S. 1994. Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins. Cell Mol. Biol. (Noisy-le-grand) 40, 863-870.
23 Montal, M. 1998. Mitochondria, glutamate neurotoxicity and the death cascade. Biochim. Biophys. Acta 1366, 113-126.   DOI
24 Morgan, D. M. 1998. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol. Biol. 79, 179-183.
25 Neuzil, J. and Stocker, R. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712-16719.   DOI
26 Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R. and Brown, A. L., et al. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433.   DOI
27 Pervaiz, S. 2003. Resveratrol: from grapevines to mammalian biology. FASEB J. 17, 1975-1985.   DOI
28 Reiner, A. and Levitz, J. 2018. Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert. Neuron 98, 1080-1098.   DOI
29 Fukui, M., Choi, H. J. and Zhu, B. T. 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 800-813.   DOI
30 Cassano, T., Pace, L., Bedse, G., Lavecchia, A. M., De Marco, F., Gaetani, S. and Serviddio, G. 2016. Glutamate and Mitochondria: Two prominent Players in the oxidative stress-induced neurodegeneration. Curr. Alzheimer Res. 13, 185-197.   DOI
31 Khatri, N., Thakur, M., Pareek, V., Kumar, S., Sharma, S. and Datusalia, A. K. 2018. Oxidative stress: major threat in traumatic brain injury. CNS Neurol. Disord. Drug Targets 17, 689-695.   DOI
32 Lai, T. W, Shyu, W. C. and Wang, Y. T. 2011. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol. Med. 17, 266-275.   DOI
33 Rolo, A. P. and Palmeira, C. M. 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212, 167-178.   DOI
34 Springer, M. and Moco, S. 2019. Resveratrol and its human metabolites-effects on metabolic health and obesity. Nutrients 11, 143.   DOI
35 Wang, R. and Reddy, P. H. 2017. Role of glutamate and NMDA receptors in Alzheimer's disease. J. Alzheimers Dis. 57, 1041-1048.   DOI
36 Zhou, X., Chen, Z., Yun, W., Ren, J., Li, C. and Wang, H. 2015. Extrasynaptic NMDA receptor in excitotoxicity: function revisited. Neuroscientist 21, 337-344.   DOI